T. Rowe Price Associates’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

T. Rowe Price Associates’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,589	Closed	-$853K	–	2647
2018 Q2	$853K	Buy	+8,589	New	+$742K	﹤0.01%	1910
2013 Q4	–	Sell	-176,729	Closed	-$5.16M	–	2535
2013 Q3	$5.16M	Hold	176,729	–	–	﹤0.01%	1418
2013 Q2	$4.06M	Buy	+176,729	New	+$4.46M	﹤0.01%	1443

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates's CBPO Position: Q3 2018 in Review

T. Rowe Price Associates sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 8,589 shares — an estimated $853K sold.

T. Rowe Price Associates first reported a position in CBPO in Q2 2013 and held it in 3 quarters. The position peaked at $5.16M in Q3 2013. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

T. Rowe Price Associates reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
T. Rowe Price Associates sold 8,589 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $853K.
T. Rowe Price Associates first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 3 quarters.
T. Rowe Price Associates's China Biologic Products Holdings, Inc. position peaked at $5.16M in Q3 2013.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.